David R Lorenz1, Shibani S Mukerji1,2, Vikas Misra1, Hajime Uno3, Benjamin B Gelman4, David J Moore5, Elyse J Singer6, Susan Morgello7, Dana Gabuzda1. 1. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute. 2. Department of Neurology, Massachusetts General Hospital. 3. Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusett. 4. Department of Pathology, University of Texas Medical Branch, Galveston, Texas. 5. Department of Psychiatry, University of California San Diego, La Jolla. 6. Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California. 7. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract
OBJECTIVE: People with HIV (PWH) have increased prevalence of multimorbidity and frailty at younger ages compared with the general population. This study investigated individual and combinatorial effects of neuropsychiatric and medical comorbidities as predictors of frailty in PWH. DESIGN: Analysis of data from the National NeuroAIDS Tissue Consortium, a longitudinal observational cohort. METHODS: Five hundred and twenty-four PWH over age 40 years were classified using Fried's Frailty criteria. Twelve comorbidities were documented from longitudinal data and associations between individual and co-occurring comorbidities with frailty were assessed using weighted network and logistic regression analyses. RESULTS: At frailty assessment between 2015 and 2020, median age was 61 years, 76% were men, 94% were on antiretroviral therapy (ART), 73% had two or more comorbidities, 24% were frail, and 52% were prefrail. Among individual comorbidities, highest odds of frailty were in participants with depressive symptoms [adjusted odds ratio (aOR), 95% confidence interval (CI) 3.48 (2.22-5.46)], followed by bone disease and chronic obstructive pulmonary disease (COPD) [2.47 (1.28-4.72) and 2.13 (1.36-3.34), respectively]. Among co-occurring comorbidities, highest odds of frailty were in participants having depressive symptoms with diabetes, hypertension, or obesity [aORs (95% CIs) 5.29 (2.32-12.08), 5.21 (2.65-10.40), 4.85 (2.39-9.95), respectively], cognitive impairment with diabetes or renal disease [2.81 (1.38-5.68) and 2.53 (1.26-5.03), respectively], renal disease with cardiovascular disease [2.81 (1.32-6.01)], and diabetes with obesity [2.76 (1.39-5.45)]. CONCLUSION: Co-occurrence of depressive symptoms, cognitive impairment, diabetes, or renal disease with other medical conditions substantially increases odds of frailty in older PWH. Identifying and treating these comorbidities may help to reduce functional decline with aging in PWH.
OBJECTIVE: People with HIV (PWH) have increased prevalence of multimorbidity and frailty at younger ages compared with the general population. This study investigated individual and combinatorial effects of neuropsychiatric and medical comorbidities as predictors of frailty in PWH. DESIGN: Analysis of data from the National NeuroAIDS Tissue Consortium, a longitudinal observational cohort. METHODS: Five hundred and twenty-four PWH over age 40 years were classified using Fried's Frailty criteria. Twelve comorbidities were documented from longitudinal data and associations between individual and co-occurring comorbidities with frailty were assessed using weighted network and logistic regression analyses. RESULTS: At frailty assessment between 2015 and 2020, median age was 61 years, 76% were men, 94% were on antiretroviral therapy (ART), 73% had two or more comorbidities, 24% were frail, and 52% were prefrail. Among individual comorbidities, highest odds of frailty were in participants with depressive symptoms [adjusted odds ratio (aOR), 95% confidence interval (CI) 3.48 (2.22-5.46)], followed by bone disease and chronic obstructive pulmonary disease (COPD) [2.47 (1.28-4.72) and 2.13 (1.36-3.34), respectively]. Among co-occurring comorbidities, highest odds of frailty were in participants having depressive symptoms with diabetes, hypertension, or obesity [aORs (95% CIs) 5.29 (2.32-12.08), 5.21 (2.65-10.40), 4.85 (2.39-9.95), respectively], cognitive impairment with diabetes or renal disease [2.81 (1.38-5.68) and 2.53 (1.26-5.03), respectively], renal disease with cardiovascular disease [2.81 (1.32-6.01)], and diabetes with obesity [2.76 (1.39-5.45)]. CONCLUSION: Co-occurrence of depressive symptoms, cognitive impairment, diabetes, or renal disease with other medical conditions substantially increases odds of frailty in older PWH. Identifying and treating these comorbidities may help to reduce functional decline with aging in PWH.
Authors: Katherine W Kooij; Ferdinand W N M Wit; Judith Schouten; Marc van der Valk; Mieke H Godfried; Ineke G Stolte; Maria Prins; Julian Falutz; Peter Reiss Journal: AIDS Date: 2016-01 Impact factor: 4.177
Authors: Jessica L Montoya; Catherine M Jankowski; Kelly K O'Brien; Allison R Webel; Krisann K Oursler; Brook L Henry; David J Moore; Kristine M Erlandson Journal: AIDS Date: 2019-05-01 Impact factor: 4.177
Authors: Kristine M Erlandson; Samantha MaWhinney; Melissa Wilson; Lilyana Gross; Sean A McCandless; Thomas B Campbell; Wendy M Kohrt; Robert Schwartz; Todd T Brown; Catherine M Jankowski Journal: AIDS Date: 2018-10-23 Impact factor: 4.177
Authors: Jennifer L Sutton; Rebecca L Gould; Mark C Coulson; Emma V Ward; Aine M Butler; Megan Smith; Grace Lavelle; Amy Rosa; Margaret Langridge; Robert J Howard Journal: J Am Geriatr Soc Date: 2018-12-27 Impact factor: 5.562
Authors: Susan Morgello; Gary Gensler; Seth Sherman; Ronald J Ellis; Benjamin B Gelman; Dennis L Kolson; Scott L Letendre; Jessica Robinson-Papp; Leah H Rubin; Elyse Singer; Miguel Valdes-Sueiras Journal: AIDS Date: 2019-08-01 Impact factor: 4.177
Authors: Terra V Fatukasi; Andrew Edmonds; Deborah R Gustafson; Stephen R Cole; Jessie K Edwards; Hector Bolivar; Mardge Cohen; Margaret A Fischl; Stephen Gange; Deborah Konkle-Parker; Caitlin A Moran; Michael Plankey; Anjali Sharma; Phyllis C Tien; Adaora A Adimora Journal: AIDS Date: 2019-02-01 Impact factor: 4.632
Authors: Erin E Sundermann; Kristine M Erlandson; Caitlin N Pope; Anna Rubtsova; Jessica Montoya; Alison A Moore; Catia Marzolini; Kelly K O'Brien; Savita Pahwa; Brendan A I Payne; Leah H Rubin; Sharon Walmsley; Norman J Haughey; Monty Montano; Maile Y Karris; Joseph B Margolick; David J Moore Journal: AIDS Res Hum Retroviruses Date: 2019-09-10 Impact factor: 1.723